NCT00004795View on ClinicalTrials.gov

Phase II/III Randomized, Double-Blind, Placebo-Controlled Study of Dehydroepiandrosterone in Women With Mild to Moderate Systemic Lupus Erythematosus

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

190

Participants

Timeline

Start Date

August 31, 1994

Conditions
Systemic Lupus Erythematosus
Interventions
DRUG

dehydroepiandrosterone

All Listed Sponsors
collaborator

Northwestern University

OTHER

lead

National Center for Research Resources (NCRR)

NIH